Clinical trials for Polymyalgia rheumatica

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Polymyalgia rheumatica. For all clinical trials, go to clinical trials search

This list shows clinical trials for Polymyalgia rheumatica

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Polymyalgia rheumatica
Title Recruitment status Location
Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD Recruiting United Kingdom
Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST Recruiting United Kingdom
American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis Recruiting United Kingdom
Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis Recruiting United Kingdom
Rituximab versus cyclophosphamide in connective tissue disease-ILD Recruiting United Kingdom
A clinical study, assessing the effect of 2 new drugs (AIN457, ACZ885) as compared to a standard drug (corticosteroids) to relief pain and inflammation in patients with Polymyalgia rheumatica (PMR) Not Recruiting United Kingdom
A study assessing the efficacy and safety of Lodotra® compared to prednisone IR in subjects suffering from PMR. Not Recruiting United Kingdom
A placebo-controlled, proof-of concept study of the efficacy and safety of gevokizumab in the treatment of patients with giant cell arteritis Not Recruiting United Kingdom
A study assessing the efficacy and safety of Lodotra® compared to prednisone IR in subjects suffering from PMR. Not Recruiting United Kingdom
An open-label, phase II dose titration study of ACZ885 (human anti-IL-1beta monoclonal antibody) to assess the clinical efficacy, safety, pharmacokinetics and pharmacodynamics in patients with NALP3 mutations - A2102 Not Recruiting United Kingdom

Page last reviewed:

Next review due: